TheraPEAK® T-VIVO® Cell Culture Medium, chemically defined, non-animal origin (NAO), serum-free, with recombinant proteins, 1 L bag
Bone Marrow CD34+ Cells, ≥2 million cells, cryopreserved, positively selected
TheraPEAK® T-VIVO® Cell Culture Medium, chemically defined, non-animal origin (NAO), serum-free, with recombinant proteins, 1 L bottle
Fixed-volume reaction vessel for the 4D-Nucleofector® LV Unit PRO for research and process development. Use in combination with P3 Nucleofector® Solution LV Sets.
For closed, scalable large-scale transfection of up to 1x109 cells.
Bone Marrow CD34+ Cells, 100,000 cells, cryopreserved, positively selected
Bone Marrow CD34 Cells+, 500,000 cells, cryopreserved, isolated from mononuclear cells using positive immunomagnetic selection
Bone Marrow CD34+ Cells, 300,000 cells, cryopreserved, positively selected
-
TheraPEAK® X-VIVO® Hematopoietic Cell Culture MediumSerum-free, GMP produced medium for cell therapy applications
-
References - X-Vivo™Overview of relevant references
-
Instructions for Use – TheraPEAK® X-VIVO® Cell Culture MediumInstructions for how to use the X-VIVO® Media Series
-
TheraPEAK® T-VIVO® Cell Culture Medium – OverviewView or download this document for a comprehensive overview and learn how the chemically defined TheraPEAK® T-VIVO® Medium enhances T-cell culture and accelerates therapy development.
-
Instructions for Use – TheraPEAK® T-VIVO® Cell Culture Medium for Gamma Delta (γδ) T CellsInstructions for how to culture gamma delta (γδ) T Cells using TheraPEAK® T-VIVO® Cell Culture Medium
-
Instructions for Use - TheraPEAK® T-VIVO® Cell Culture MediumInstructions for how to use the TheraPEAK® T-VIVO® Cell Culture Media Series
-
A Novel Chemically Defined Medium Supports Superior Cross-platform T-cell ExpansionThis poster showcases how the chemically defined TheraPEAK® T-VIVO® Medium supports superior T-cell expansion across different platforms.
-
A Non-Viral Method for Modifying and Expanding Primary T CellsLearn how Lonza’s Cocoon® Platform, 4D-Nucleofector® LV Unit and X-VIVO® 15 Medium are integrated to enable non-viral genetic modification and subsequent expansion of primary T cells in a functionally-closed, automated workflow.
-
Serum-free Media FFM Part Codes2019 change of all RUO Media to FFM production overview of RUO and new FFM part codes (X-VIVO not included)
-
Two Distinct Activation Methods Yield Clinical-Scale Expansion of Peripheral Blood Derived γδ T CellsIn this study, we demonstrate that billions of γδ T cells can be generated from peripheral blood mononuclear cells (PBMCs) with two distinct activation methods, using TheraPEAK® T-VIVO® Medium.